EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Glyoxalase 1 Regulates Methylglyoxal-Derived Nucleic Acid Adduct Burden

Alana Battad, Francisco Nunez, Seigmund W T Lai, Elise Desjarlais, Sarah C Shuck iD

Chemical Research in Toxicology · 2026

DOI: 10.1021/acs.chemrestox.6c00169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2026. Verfasst von Alana Battad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Cancer Metabolism, City of Hope National Medical Center, Duarte, California91010, United States. Hauptthemen laut MEDLINE: Pyruvaldehyde, Lactoylglutathione Lyase, DNA Adducts, RNA. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increased metabolic stress associated with diabetes and cancer increases the level of reactive dicarbonyl molecules that covalently modify nucleic acids. Methylglyoxal (MG), one of the most abundant endogenous dicarbonyl electrophiles, reacts with guanine bases in DNA and RNA to form covalent adducts that compromise genomic and RNA integrity. The primary MG-derived adduct in DNA is N2-carboxyethyl deoxyguanosine (CEdG), and in RNA, it is N2-carboxyethyl guanosine (CEG). CEdG is mutagenic, while CEG decreases mRNA stability and impairs translation. To prevent adduct formation, cells utilize the glyoxalase pathway, which is the primary pathway for detoxifying MG. Glyoxalase 1 (GLO1) is the first enzyme in this pathway. While GLO1 is frequently dysregulated in metabolic disease and cancer, its role in regulating MG-induced nucleic acid adduct burden and the downstream functional consequences remains incompletely defined. Here, we demonstrate that the genetic ablation of GLO1 significantly increases the accumulation of MG-derived DNA and RNA adducts. We found that an elevated CEdG adduct burden is associated with increased DNA strand breaks, whereas increased CEG modifications are associated with reduced translational efficiency. These findings establish GLO1 as a critical regulator of the endogenous nucleic acid modification burden and mechanistically link metabolic stress-derived chemical lesions to genome instability and translational dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyruvaldehydeLactoylglutathione LyaseDNA AdductsRNAAnimalsMiceRNA Damage

Substanzen

PyruvaldehydeLactoylglutathione LyaseDNA AdductsGlo1 protein, mouseRNA

Autor:innen und Institutionen

  • Department of Diabetes and Cancer Metabolism, City of Hope National Medical Center, Duarte, California91010, United States.

ORCID-Profile: Sarah C Shuck

Förderung

  • NCI NIH HHS
  • National Institutes of Health (NIH)

Zitieren

APA

Battad, A., Nunez, F., Lai, S. W. T., Desjarlais, E., & Shuck, S. C. (2026). Glyoxalase 1 Regulates Methylglyoxal-Derived Nucleic Acid Adduct Burden. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.6c00169

Vancouver

Battad A, Nunez F, Lai SWT, Desjarlais E, Shuck SC. Glyoxalase 1 Regulates Methylglyoxal-Derived Nucleic Acid Adduct Burden. Chemical Research in Toxicology. 2026. doi:10.1021/acs.chemrestox.6c00169

BibTeX
@article{Battad2026,
  author = {Battad, Alana and Nunez, Francisco and Lai, Seigmund W T and Desjarlais, Elise and Shuck, Sarah C},
  title = {Glyoxalase 1 Regulates Methylglyoxal-Derived Nucleic Acid Adduct Burden},
  journal = {Chemical Research in Toxicology},
  year = {2026},
  doi = {10.1021/acs.chemrestox.6c00169}
}
Kostenlos starten →